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The tendency of users to relapse severely hinders adequate treatment of addiction. 
Physical and psychological stressors often contribute to difficulties in maintaining 
behavior change, and may play a significant role in relapse. We have previously shown 
that the activation of pituitary adenylate cyclase activating peptide (PACAP) systems in 
the bed nucleus of the stria terminalis (BNST) mediates many consequences of chronic 
stressor exposure. Hence, chronic stress substantially increased BNST PACAP levels, 
intra-BNST PACAP infusions produced the behavioral and endocrine consequences of 
stressor exposure, and BNST PACAP antagonism blocked many of the consequences of 
chronic stress. In the present set of studies, we investigated the role of BNST PACAP in 
stress-induced reinstatement of cocaine seeking. Rats self-administered cocaine (3mg/ml; 
0.5mg/ig/infusion, i.v.) for 1hr daily over 10 days, which was followed by extinction 
training in which lever pressing no longer resulted in cocaine delivery. In the first 
experiment we showed that intra-BNST PACAP infusion (1 μg; 0.5 μl per side) 
reinstated previously extinguished cocaine seeking behavior. In the second experiment 
intra-BNST infusions of the PAC1/VPAC2 antagonist, PACAP 6-38 (1 μg; 0.5 μl per 
side) blocked stress-induced reinstatement. Hence, stressor exposure (5 sec 2mA 
footshock) caused significant reinstatement of cocaine seeking behavior, which was 
blocked by intra-BNST PACAP6-38 infusion. Overall, these data suggest that BNST 
PACAP systems mediate stress-induced reinstatement to drug seeking. Understanding the 
neuropharmacology of BNST PACAP in stress-induced reinstatement and the role of 
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 CHAPTER 1. LITERATURE REVIEW 
1.1. Introduction 
Substance abuse is costly to the United States with an estimated $700 billion 
spent annually in costs related to drug intoxication, withdrawal and relapse (Feit & 
Taylor, 2015),  and the consequences of this chronic cycle, such as crime, health care, 
and lost work productivity. A better understanding of the mechanisms underlying 
substance abuse requires an investigation of the behavioral and physiological 
mechanisms that govern drug self-administration, withdrawal, and relapse (Nestler & 
Aghajanian, 1997).  
In a clinical setting, a primary problem in the treatment of substance abuse is 
the tendency of users to relapse following acute or extended periods of abstinence. For 
example, in a study of cocaine users, Higgins & colleagues (1993, 1994, 2000) noted 
that there are several treatments available (i.e. contingency management and cognitive 
behavioral therapy; for review, see Higgins et al., 2000) that can help former drug users 
become abstinent; however, the tendency to relapse is a serious and ubiquitous 
problem. On average, 25-40 percent of substance abusers will return to drug use within 
one year of receiving treatment (Scott et al., 2011). While many factors may contribute 
to drug relapse, one critical factor may be exposure to a stressor (Sinha et al., 2006). 
Furthermore, stress may become a component of the contextual setting that cues drug 
use. Upon stressor exposure, several response systems are activated including the HPA 
axis and the sympathetic nervous system (SNS), both circuits associated with emotional 
components of fear and anxiety. Hence, brain areas involved in regulating these 
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emotional processes undergo neurochemical and morphological changes after stressor 
exposure. These changes may underlie several mental health disorders (such as PTSD 
and depression; Hammack et al., 2010) including relapse to drug use. 
As will be discussed below, brain areas that modulate the stress-response 
system may be critical for stress-induced relapse of drug seeking behaviors. Our 
laboratory and others have demonstrated that neurochemical and morphological 
changes that occur as a consequence of stressor exposure likely play a role in several 
mental health disorders, such as PTSD, anxiety and affective disorders (Hammack et 
al., 2010). In this regard, the bed nucleus of the stria terminalis (BNST), a basal 
forebrain region that has been argued to represent the rostral extent of the central 
extended amygdala (Davis & Whalen, 2001) plays a key role in mediating responses to 
stressor exposure (Daniel & Rainnie, 2015; Hammack et al., 2010) and has been shown 
to mediate multiple physiological and behavioral responses to stress (Roman et al., 
2014; Walker, Toufexis & Davis, 2003). If substance abuse triggers stress-related 
circuits, changes in the BNST during drug use may become part of the neurochemical 
context for relapse after a period of abstinence when exposed to a stressor. 
Furthermore, the BNST has been highly implicated in stress-induced reinstatement (Erb 
et al., 2001; see below), and may underlie potential treatment substrates for relapse to 
drug use. 
1.2 Substance Abuse 
While substance abuse creates a large financial burden on the United States, 
substance abuse disorders also have been implicated in altering household and family 
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dynamics (Orford et al., 2013), lost careers (Measham et al., 2011), and domestic 
violence and child abuse (Schumacher, 2012). The results of a 2009 survey conducted 
by the Substance Abuse and Mental Health Services Administration demonstrate that 
23.5 million Americans sought drug abuse rehabilitation programs the previous year for 
multiple dependencies, including alcohol, nicotine, marijuana, cocaine, heroin, and 
opiates. While a predominant goal of substance abuse treatment is to help users stop 
abusing drugs, the tendency of users to relapse remains an important concern.  
Characterization of Substance Abuse 
 Substance abuse is typically characterized by recurring episodes of relapse 
following extended drug-free periods (Erb, Shaham & Stewart, 1998). The debilitating 
condition represents a state whereby drug seeking and subsequent self-administration 
dominate the user’s thoughts and behaviors. For some individuals, the tendency to 
abuse drugs continues despite detrimental side effects, such as health problems and lost 
work productivity (Feit & Taylor, 2015). While some argue that substance abuse 
represents a loss of self-control (Charbogne, Kieffer & Befort, 2014), others view 
addiction as a maladaptive neural plasticity caused by exposure to drugs of abuse (Feng 
& Nestler, 2013). Hence, multiple factors contribute to substance abuse, including the 
disordered regulation of reward systems, environmental stimuli, and vulnerable genes 
(Jasinska et al., 2014; Levran et al., 2015).  As mentioned previously, the tendency of 
users to relapse severely hinders the adequate treatment of substance abuse disorders. 
Understanding the behavioral and physiological mechanisms of relapse processes in 
substance abuse disorders is critical to determine viable targets for relapse 
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prevention. 
Behavioral processes associated with relapse 
In a clinical scenario, many behavioral processes may be activated when an 
individual returns to drug use. Bouton and colleagues (1991, 2002; see also, Rescorla, 
2004) have employed five distinct processes that may represent mechanisms underlying 
the relapse of drug-seeking behavior: spontaneous recovery describes the recovery of 
extinguished responding (i.e. drug-seeking behavior), after a period of extinction or 
abstinence; rapid reacquisition describes the condition when extinguished responding 
returns more quickly after the response is again reinforced; resurgence occurs when 
responding recovers when an alternate “second” response that has been reinforced 
during extinction is, itself, put on extinction; renewal describes the process in which 
responding reoccurs after a period of extinction when the behavior is removed from the 
extinction context; and finally, reinstatement occurs when a behavior is recovered after 
a period of extinction following exposure to the unconditioned stimulus (for a 
comprehensive review, see Bouton, Winterbauer & Vurbic, 2012). Importantly, many 
of these processes were first described in a Pavlovian conditioning scenario (for review, 
see Rescorla & Solomon, 1967; Pearce, 1987; Domjan, 2005); however, these 
processes have recently been characterized in operant conditioning paradigms. For 
example, while reinstatement procedures are now used to model the relationship 
between stress and relapse, the method was first derived as a means to study the return 
of drug-seeking after acute non-contingent exposure to a drug (Davis & Smith, 1976). 
Indeed, the term “reinstatement” has been used to describe several relapse paradigms 
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in the addiction literature (see Rescorla & Heth, 1975; Bouton & Bolles, 1979; 
Delamater, 1997). Hence, reinstatement of drug seeking behavior has been observed 
after re-exposure to the drug (drug priming), drug cues, or stressor exposure (Carroll & 
Comer, 1996; Ettenberg, MacConell, & Geist, 1996; Gerber & Stretch, 1975; Katner, 
Magalong & Weiss, 1999; Meil & See, 1996). While there are several methods to 
“reinstate” drug-seeking behavior, it is likely that these different treatments activate 
different neural pathways (Stewart, 2000). Furthermore, when recovering human 
addicts are exposed to drug stimuli or the drug itself, many report intense desire for the 
drug (Carter & Tiffany, 1999). These findings further validate the reinstatement model 
as a suitable method for studying relapse processes. 
Figure 1. The Reinstatement Model of drug relapse. Representative self-administration 
paradigm, modified from a talk given by Yavin Shaham, PhD at the Neurobiology of 
Relapse Section, Behavioral Neuroscience Branch IRP/NIDA/NIH/DHHS, Baltimore. 
During acquisition, or self-administration training, animals are allowed to lever press 
for cocaine delivery for 10 days. During this period, lever press responses increase as 
animals continually seek the drug. Immediately following acquisition of drug-seeking, 
the behavior is extinguished in the Extinction phase. Here, lever press behavior is NOT 
followed by a drug stimulus and animals learn, over a 20-day extinction period, that 
lever presses no longer produce a drug reward. Finally, test day occurs one day 
following the termination of extinction. Reinstatement has been shown to occur with 




Stress-induced reinstatement  
 
Threats to an organism’s homeostasis activate a cascade of behavioral changes 
associated with fear, anxiety, and emotional distress (Hammack et al., 2010). Stressor 
exposure activates the HPA axis, a central circuit that serves to maintain an organism’s 
homeostasis by promoting necessary changes in physiological and behavioral responses 
to a stimulus. This action is dependent on stress hormone corticotropin releasing 
hormone (CRH) release (Tsigos & Chrousos, 2002). However, CRH activation in extra-
hypothalamic brain regions may mediate some of the behavioral and physiological 
symptoms of stressor exposure, including stress-induced relapse. Notably, alterations in 
HPA axis function have been linked to anxiety and depressive disorders (Gold & 
Chrousos, 2002; Arborelius, Owens, Plotsky & Nemeroff, 1999), and may play a role 
in properties of addiction, such as relapse.  
As noted above, drug-seeking can be accurately and reliably reinstated in 
response to stressor exposure (Erb, Shaham & Stewart, 1998). In a standard stress-
induced reinstatement procedure (discussed in Chapter 2), rats self-administer cocaine 
via lever-press response, and then have the behavior extinguished, in which subsequent 
lever presses no longer deliver cocaine. After extinction, exposure to a stressor (i.e. 
intermittent unpredictable electrical footshock) can reinstate drug-seeking on the lever 
previously associated with drug delivery.  
Many studies have investigated the neural circuits underlying stress-induced 
reinstatement (Kalivas & Volkow, 2014; McFarland et al., 2004; Sinha, 2001). For 
example, Erb & Stewart (1999) have implicated activation of CRH (see below) 
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in stress-induced relapse. Additionally, Shaham and colleagues (1997, 2000) 
demonstrated that an acute intracerebroventricular (ICV) injection of CRH mimicked 
stressor exposure and caused reinstatement, whereas the ICV injection of a CRH 
antagonist, α-helical CRH, blocked stress-induced reinstatement in heroin-trained rats. 
Furthermore, in a follow-up study done in cocaine-trained rats, Shaham, Erb, et al. 
(1998) showed that CRH receptor antagonists (D-Phe CRH and CP-154,526, 
respectively) also attenuated reinstatement to drug-seeking. When tested in drug-
primed animals, these manipulations had no effect, indicating an important role of CRH 
specifically in the stress-induced reinstatement paradigm. Initially, the sites of CRH 
action were unclear; however, subsequent studies implicated the BNST as a critical site 
for stress-induced reinstatement of drug seeking behavior.  
1.3 The Bed Nucleus of the Stria Terminalis (BNST) 
 The BNST has been linked to anxiety- and stress-responding in both clinical and 
laboratory settings (Avery et al., 2015; Walker, et al. 2003). Hence, the structure has 
been implicated in numerous neurochemical, morphological and physiological 
alterations after stressor exposure (Dumont, Rycroft, Maiz & Williams, 2008). A 
naturally heterogeneous structure, activity in the BNST may be critical for creating and 
maintaining these alterations long-term. The BNST has been subdivided into several 
different subregions based on neuronal morphology, afferent and efferent connections, 
and neurochemistry (Avery et al., 2015). Moreover, neurons within the BNST express 
numerous receptor subtypes that bind multiple neuropeptides, such as CRH, 
neurotensin, and encephalin. This heterogeneity, and the neuropeptides 
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present, suggests that the regulation of BNST activity is complex. Several researchers 
have implicated the BNST oval nucleus in the mediation of emotional (i.e. stressful) 
responses (Daniel & Rainnie, 2015). Indeed, the BNST oval nucleus receives CRH 
inputs from the central amygdala (CeA; an area responsible for some autonomic and 
behavioral components of emotion), receives projections from the basolateral amygdala 
(BLA; necessary for eliciting fear responses), hippocampus, and medial prefrontal 
cortex (mPFC), and projects to the paraventricular nucleus (PVN; in the 
hypothalamus), limbic structures, and brainstem nuclei (Crestani et al., 2013). The 
BNST is thought to serve as a relay station between limbic systems and emotional 
processing systems, as the structure projects to and receives projections from areas 
responsible for both the emotional and physiological responses to a stressor, and 
therefore may be prominent in mediating stress disorders (i.e. stress-induced relapse; 
Roman et al., 2014; Hammack & May, 2015).       
Neurochemistry 
 As discussed above, CRH release from extrahypothalamic areas like the BNST 
may be an important component of the activation of anxiety- and fear-like behaviors. In 
several studies investigating fear responses, an ICV injection of CRH increased startle 
and caused a depressive-like state in rodents (Lee & Davis, 1997), an effect mediated 
by the BNST.  
 The BNST also receives projections from the ventral norepinephrine (NE) 
bundle, a cluster of neurons originating from the locus coeruleus and lateral tegmental 
nuclei. Projections from the lateral tegmental nuclei specifically target the 
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BNST, CeA, hypothalamus, and septum (Aston-Jones, et al., 1999; Aston-Jones et al., 
1997; Delfs, et al., 1998) and are activated most prominently by stressor exposure 
(Brener, et al., 1996). Specifically, the BNST and CeA receive projections from the NE 
bundle, a connection that has been implicated in the stress responses associated with 
CRH (Delfs et al., 1998). Indeed, both extrahyothalamic sub-structures contain dense 
populations of CRH-immunoreactive cells (Shaham, Erb & Stewart, 2000). 
Furthermore, stressors have been shown to increase CRH mRNA in CeA (Hammack et 
al., 2009; Keifer, Hurt, Ressler & Marvar, 2015). The role of the BNST (and not the 
amygdala) is further supported by prior studies of CRH administration in the BNST and 
CeA of animals allowed to lever-press for cocaine (Erb & Stewart, 1999). In this set of 
studies, rats were injected with a CRH receptor antagonist, D-Phe CRH in the BNST or 
amygdala during tests of reinstatement, fifteen minutes prior to the administration of a 
physical footshock stressor. A different group of rats was injected with CRH itself into 
either the BNST or CeA to determine whether the presence of CRH in the system, even 
without stressor exposure, would induce reinstatement to drug-seeking. Notably, only 
injections (both antagonist and CRH itself) into the BNST had any effect – injections of 
either into the amygdala had no effect on reinstatement behaviors. That is, the injection 
of CRH receptor antagonist into the BNST caused an attenuation of stress-induced 
reinstatement when it occurred along with a footshock, and injection of CRH itself 
caused reinstatement-like behaviors when animals were tested in the context in which 
they had acquired self-administration behavior. This series of experiments suggests the 
BNST, but not the CeA, is a critical structure mediating the effects of stress-
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induced reinstatement after the self-administration of drugs.  
Stress & the BNST 
 A critical component of the stress circuit, the BNST receives projections from 
extra-hypothalamic regions including the amygdala, prefrontal cortex, and 
hypothalamus; the BNST projects to and regulates HPA axis activity in response to a 
stressor exposure. Indeed, the BNST is not only activated by stressor exposure, but may 
mediate some consequences of the stressor itself (Lezak et al., 2014). The BNST has 
also been shown to exhibit changes of neuroplasticity in response to chronic stress 
(Hammack et al., 2010; Pego et al., 2008).  
 While activation of the BNST mediates the behavioral and physiological 
responses to stressor exposure (Lezak, et al., 2014), its neurochemistry and morphology 
is also altered with repeated exposure to stress. Hence, in a study of unpredictable stress 
in rats, Pego and colleagues (2008) noticed an increase in BNST volume and behavioral 
manifestations of stress (i.e. anxiety-like behavior) after 28 days of chronic stressor 
exposure.  However, it is important to note that certain sub-regions of the BNST may 
be more receptive to prolonged stressor exposure and have greater morphological and 
physiological changes than anatomically similar sub-regions. For example, our labotory 
has observed alterations in pituitary adenylate cyclase-activating peptide (PACAP) and 
PAC1 receptor mRNA levels in the anterior dorsolateral BNST (BNSTld), but not the 
ventral BNST (vBNST), following a repeated variate stress paradigm in rats 
(Hammack, Cheung et al., 2009). Additionally, several research teams have observed 
increases in CRH following the same stress paradigm in the BNSTld, but not 
 11 
other regions of the BNST – changes that the researchers link to an increase in anxiety-
like behavior (Lee & Davis, 1997; Schulkin, Gold & McEwen, 1998). Hence, stressor 
exposure and the activation of the HPA axis may be linked to PACAP and CRH 
signaling in the BNST. 
1.4 Pituitary Adenylate Cyclase-Activating Peptide (PACAP) 
 PACAP has been implicated as a key regulator of signaling in stress-related 
brain regions (Hammack & May, 2015; Stroth et al., 2011). First discovered in 1989 by 
Miyata and colleagues, the peptide is well-conserved, existing in both the 27- and 38-
amino acid form. A neurotrophic factor, PACAP promotes cell survival of multiple 
neuron types, including progenitor cells, dorsal root ganglion cells, cerebellar granule 
cells, and peripheral sympathetic neurons (Stroth, et al., 2011). Importantly, PACAP 
has been shown to increase cell survival in response to stressor exposure (Stroth et al., 
2013). The peptide belongs to the vasoactive intestinal peptide (VIP) – secretin – 
GHRH-glucagon family, and shares multiple characteristics with peptide VIP (Miyata 
et al., 1989; Miyata et al., 1990). PACAP38 predominates over PACAP27 in the 
nervous system, and PACAP-ergic fibers innervate multiple stress-related regions; 
large populations of these fibers are found in the hypothalamus, amygdala, and BNST. 
As mentioned previously, systemic and environmental stressors both activate the HPA 
axis and sympathetic nervous system (SNS), processes deeply connected to the 
hypothalamus. Indeed, researchers have postulated that PACAP regulates stress 
hormone synthesis in a chronic-stress paradigm (Stroth et al., 2011).  
 PACAP, because it has a similar morphology to peptide VIP, has been 
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shown to bind to multiple receptor subtypes: PAC1 (exclusively binds PACAP), 
VPAC1, and VPAC2 (both of which bind PACAP and VIP; for reference, see May, et 
al., 2010). By binding to these receptors, PACAP can have various effects on 
intracellular mechanisms (such as membrane depolarization and neurotransmitter 
release; see Harmar et al., 2012; Shioda, et al., 1996), including neurotrophic and 
neurotransmitter-like effects.  
Role of PACAP in Stress-related Behavior 
 As mentioned previously, our laboratory and others have argued that PACAP 
plays a crucial role in stress responding (for review, see Hammack et al., 2010; Lezak 
et al., 2014; Mustafa et al., 2015; Missig et al., 2014). Hence, PACAP may also play an 
important role in addiction processes. Indeed, addiction, or substance abuse, is itself a 
chronic stressor, and as noted above, many addiction processes may be regulated by 
stressor exposure. PACAP and PAC1 receptors are highly expressed in areas that 
project to the HPA axis, and several studies have demonstrated the importance of 
PACAP in HPA signaling (Stroth et al., 2011). Furthermore, Stroth and colleagues 
(2011) demonstrated an increase in CRH transcription in response to PACAP in 
hypothalamic cells, and ICV administration of PACAP increased CRH mRNA in the 
PVN (Hashimoto et al., 2011). Finally, PACAP null mice have exhibited impaired 
long-term HPA axis activation in response to chronic stressors, an idea that supports the 
importance of PACAPs role in HPA axis regulation during a stressful situation (Vaudry 
et al., 2005; Hammack et al., 2010). Interestingly, mice deficient in PACAP, when 
exposed to ethanol, demonstrated a higher tendency to seek the substance than 
 13 
control mice (Tanaka et al., 2010). 
 Our labotory has demonstrated that an intra-BNST infusion of PACAP mimics 
behavior and physiological responses to stressor exposure (see Hammack, Cheung, et 
al., 2009; Hammack et al., 2010). For example, the exposure of rats to a seven day 
repeated variate stress paradigm produces anxiety- and anorexic-like behaviors. These 
behaviors, when analyzed, were associated with a significant increase in PACAP and 
PAC1 receptors in the BNST. Bilateral intra-BNST infusion of PACAP38 on its own 
was sufficient to cause the same stress-related behaviors, including anorexic- and 
anxiety-like behaviors. Additionally, bilateral intra-BNST infusions of a PAC1 receptor 
antagonist reduced the stress-induced consequences of repeated variate stress, 
suggesting that PACAP in the BNST is necessary for the stress responses observed 
(Roman et al., 2014). Combined, these data implicate PACAP as an important regulator 
of stress-related pathologies (Hammack et al., 2012). 
 A growing literature has discussed PACAPs important role in the modulation of 
stress and anxiety. The present studies were designed to help further the understanding 
of PACAP’s role in stress-induced reinstatement. Hence, we propose that PACAP may 
drive BNST CRH to produce stress-induced reinstatement. Data from these 
experiments will help elucidate PACAP’s role in activation of the HPA axis and how 
stressor exposure triggers relapse behaviors after a period of abstinence. Additionally, 
we will gain a better understanding of how stress contributes to the development of 
stress-related pathologies, such as stress-induced relapse and PTSD. 
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CHAPTER 2: INTRA-BED NUCLEUS OF THE STRIA TERMINALIS (BNST) 
PITUITARY ADENYLATE CYCLASE-ACTIVATING PEPTIDE (PACAP) 
REINSTATES COCAINE SEEKING IN RATS 
 
2.1 Introduction 
 PACAP is expressed in several brain regions associated with the activation of 
the HPA axis after stressor exposure, including the BNST (Vaudry et al., 2005). 
PACAP has also been argued to be a key regulator of stress responses (Stroth, 
Holighaus et al., 2011), and may therefore underlie some behavioral processes of 
stress-induced relapse. However, the brain circuits by which PACAP may regulate 
these behavioral responses are still under investigation. Combined, BNST PACAP’s 
mediation of stressor exposure (Hammack et al., 2010) and the role of PACAP in 
regulation of the HPA axis in response to stressor exposure, suggest that BNST PACAP 
signaling may be important for stress-induced reinstatement to drug-seeking. 
 The first study in this set of experiments examined how a bilateral intra-BNST 
infusion of PACAP agonist (PACAP38) affects reinstatement to drug-seeking behavior 
after a period of extinction. Based on the proposed role of BNST PACAP in response to 
stressor exposure, we hypothesized that PACAP38 infusion would mimic stressor 
exposure and cause reinstatement to drug-seeking in rats who had previously 
undergone extinction of the drug-seeking behavior. This study helps further the 
understanding of BNST PACAP in stress-induced relapse and, combined with results 






 Adult male Sprague-Dawley rats (n=29; 225-250 g upon arrival), obtained from 
Charles River Laboratories (Canada), were individually housed and received water and 
rat chow ad libitum (except when specified). After delivery, rats were allowed to 
habituate to their home cage for one week before undergoing surgeries. Rats were 
maintained on a 12 hr light/dark cycle (lights on at 07:00 hours) and all 
experimentation occurred with lights-on (between 07:30-11:30). All procedures were 
approved by the Institutional Animal Care and Use Committee at the University of 
Vermont.  
Surgeries 
 All rats underwent a dual surgery. The first was a jugular vein catheter 
implantation. Rats were anesthetized using isofluorane vapor (1.5-4.0%) and all 
surgical procedures were conducted using aseptic techniques. Catheters were 
constructed using methods described by Fuchs et al., 2004 and consisted of external 
guide cannula with screw-type connectors (Plastic One Inc., Roanoke, VA, USA), 
silastic tubing (10 cm; SAI Infusion Technology, Lake Villa, IL, USA), and prolite 
polypropylene monofilament mesh (2 cm diameter; Biomedical Structures, Warwick, 
RI, USA). The end of the catheter was inserted into the right jugular vein, secured with 
suture, and exited on the rats back, posterior to the shoulder blades. To maintain 
patency, catheters were flushed once daily for 6 days after surgery with 0.2 ml 
heparinized saline. For the duration of the experiment, each animal received 0.1 ml 
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heparinized saline immediately following each self-administration session to ensure 
catheter patency.  
 Immediately following the jugular catheritization, all animals were re-sterilized 
and secured with blunted earbars in a stereotaxic apparatus (David Kopf Instruments, 
Tujunga, CA, USA) for intra-BNST cannulation. A midline incision was made and the 
skull was exposed and cleaned. Four burr holes were drilled and screws were fixed to 
help secure the cannula and dental cement skullcap. Guide cannula (22 guage, Plastics 
One Inc., Roanoke, VA, USA) were mounted onto each stereotaxic arm and aimed at 
an angle of 20 degrees just dorsal to the oval BNST (from bregma: AP= -0.1, ML= 
+3.8, DV= -5.3). Wire stylettes extending 1 mm past the tip were inserted into each 
guide cannula, and cemented in place. Animals received subcutaneous injections of 
lactated Ringer’s solution and an analgesic (5 mg/kg Metacam, Boehringer Ingelheim, 
Vetmedica, St. Joseph, MO, USA; administered once immediately after the dual 
surgery and once the following day). Once awake, rats were returned to their home 
cages for 7 days post-surgery recovery, during which all rats were observed and 
weighed daily.  
Cocaine Self-Administration/Acquisition 
 Seven days post-surgery, all rats were given the opportunity to self-administer 
cocaine (cocaine hydrochloride 3.0 mg/ml obtained from PENRO Specialty 
Compounding, Colchester, VT, USA) during daily 1-hr sessions for 10 days according 
to a fixed-ratio 1 schedule of reinforcement. At the start of each session, the catheter 
was connected to a swivel via polyethylene 20 tubing that was encased 
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in steel spring lashes (Plastics One Inc., Roanoke, VA, USA). Self-administration 
occurred in standard operant conditioning chambers (26x25x19 cm) linked to a 
computer data collection program (MED-PC, Med Associates Inc., St. Albans, VT, 
USA). The chambers were equipped with two levers (one active and one inactive for 
the purposes of this experiment), a stimulus light above each lever, and a house light. 
After the animals were placed in the chamber, a two minute period elapsed before the 
stimulus light came on above the active lever (signaling drug availability), allowing the 
animal time to orient to his surroundings. Lever presses on the active lever resulted in a 
0.5-s cocaine infusion and a 0.5-s flashing presentation of the white stimulus light 
above the active lever. In an effort to help the animals acquire cocaine-seeking 
behavior, several manipulations were made during the 10 days of acquisition: all rats 
received mild food restriction (20 g rat chow per day) on days 1-2 of acquisition. 
During this two day mild food restriction period, home-cage rat chow was crushed and 
mixed with water to create a paste that was coated onto the active lever prior to the rats’ 
self-administration session. One days 3-10 of acquisition, all animals received ad 
libitum food and water, and the lever was no longer baited. Moreover, the amount of 
drug delivered per infusion was decreased over the acquisition period, in order to 
increase cocaine-seeking behaviors, with the following schedule: days 1-3, 1.0 
mg/kg/infusion; days 4-7, 0.75 mg/kg/infusion; days 8-10, 0.50 mg/kg/infusion.  
Extinction 
 All rats then experienced daily 1-hr extinction sessions for 20 days during which 
active lever presses no longer resulted in drug delivery reward. At the completion 
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of extinction, lever press responses ~0-1 per session. 
Reinstatement to cocaine seeking 
 On the day following the last extinction session, rats were infused into the 
BNST with 1.0 μg PACAP38 (American Peptide Co., Sunnyvale, CA, USA; 0.5 μl per 
side) or equivolume 0.05% BSA saline vehicle. For each infusion, the stylette was 
removed, and an internal cannula that extended 1 mm beyond the end of the guide 
cannula was inserted. This was connected to a 10ul Hamilton syringe via PE50 plastic 
tubing. Following the infusion, the internal cannula was kept in place for one minute to 
allow for diffusion of the drug away from the infusion site. Immediately following 
bilateral infusion, the rat was placed in the operant conditioning chamber and allowed 
to lever press (without cocaine reward delivery). Active and inactive lever presses were 
recorded for 1 hr. 
Histology 
 One day after infusions, rats were anesthetized with Beuthanasia-D (sodium 
pentobarbital; Zoetis Inc., 333 Portage Street, Kalamazoo, MI, USA) solution and 
perfused transcardially with 200 ml saline (0.9%) with 0.1% heparin (Sagent, 
Schaumburg, IL, USA) followed by 100 ml of 10% formalin solution (Fisher Scientific, 
Atlanta, GA, USA). Brain tissues were post-fixed at 4°C for a minimum of 24 hr in 
10% formalin. Fixed tissue was then cut using a cryostat, and sections were collected at 
60 μm thickness. Sections were dry mounted, stained with cresyl violet stain, and 




 Lever press responding during each phase of the experiment was analyzed using 
repeated measure ANOVAs. Pearson’s correlation coefficients were calculated to 
examine relationships between average daily cocaine intake and reinstatement 
responding. All main effects were analyzed with appropriate post-hoc comparisons for 
significance. Effects were noted as significant at p<0.05. Rats that did not complete 
behavioral testing (n=1), or whose cannula were placed beyond the BNST (n=2) were 
not included in data analysis.  
2.3 Results 
 Data from 29 animals were used in the analyses for the tests for reinstatement, 
as post-test histological examination of injection sites for these rats were found to be 
placed appropriately in the BNST. Two animals had improperly placed cannula and 
were excluded from analyses. Figure 2 portrays the distribution of cannula placements 
in analyzed animals.  
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Figure 2: BNST Cannula Placements. Cannula placements for Experiment 1 are 
depicted above such that enclosed red dots represent a 1 mm extension beyond the tip 
of the cannula. Rats were included in the analysis if their placement resided within a 












 Rats self-administered an average [mean (±SEM)] of 4.03 (±0.79) infusions of 
cocaine HCl per hour, 1.0 mg/kg/infusion, on days 1-3 of acquisition; 6.72 (±1.01) 
infusions per hour, 0.75 mg/kg/infusion, on days 4-7 of acquisition; and 10.36 (±0.68) 
infusions per hour, 0.5 mg/kg/infusion, on days 8-10 of acquisition (Figure 3). The 
mean (±SEM) number of responses made on the inactive lever on days 1-3 of 
acquisition was 3.58 (±1.94); 2.50 (±1.01) on days 4-7; and 0.96 (±0.75) on days 8-10 
of acquisition. As demonstrated, by the last day of acquisition, responding on the 
inactive lever was uniformly low (Figure 3). Animals had an affinity for active lever 
presses, as responding solely on the active lever produced cocaine delivery; hence, 
active and inactive lever presses differed by the end of acquisition, (F(2,17)=2.52, 
p<0.05). The number of active lever presses was significantly higher (p<0.05) than 
inactive lever presses from Day5 of acquisition through Day10, the end of the self-
administration period.  
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Figure 3: Self Administration training during Experiment 1.  
 
Extinction 
 The mean (±SEM) number of responses made on the active lever on the first two 
days of extinction were 6.54 (±1.15) and 12.64 (±2.07), respectively. By the end of 
extinction, all rats had reached 5 or fewer responses (Figure 4). Inactive lever responses 
remained uniformly low throughout extinction. In contrast to the otherwise consistently 
decreasing lever press responses made over extinction, on Extinction Day 13, a 30-min 
fire alarm interrupted animals actively involved in extinction sessions (Figure 4; day 
13). This interruption produced a noticeable effect solely on active lever press 
responses, perhaps demonstrating stress- induced reinstatement to drug seeking.   























Figure 4: Extinction Training during Experiment 1. Extinction sessions occurred during 
the 20 days after self-administration training. Significant increases in responding on the 
first three days of extinction indicate awareness by the animals that the drug is no 
longer being delivered. On extinction day 13, a 30 min fire alarm interrupted extinction 
training, creating a stress-induced reinstatement-like response strictly on the active 
lever (previously associated with cocaine delivery).  
 
Test for reinstatement 
 The mean (±SEM) number of lever presses made in the 1-hr session on the last 
day of extinction training was 0.53 (±0.11). The mean (±SEM) number of responses  
made on the active and inactive levers one day after the last day of extinction (during 
the test for reinstatement) is shown in Figure 5. No significant differences in 
responding were found between animals infused with BSA vehicle solution. However, 
bilateral intra-BNST infusion of PACAP agonist PACAP38 significantly reinstated 
drug-seeking behavior (13.81 (±2.68) lever presses) on the lever previously 
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associated with cocaine delivery. A repeated measures ANOVA for responses on the 
active lever revealed a significant effect of day, F(1, 27)=12.08, p<0.01, where active 
lever press responses were significantly higher on test day than on the last day of 
extinction. Furthermore, there was a significant day by treatment interaction, 
F(1,27)=9.25, p<0.01, where only rats who received PACAP38 increased responding 
on the active lever during the test for reinstatement (Figure 5). It can be seen in Figure 
5 that responding on the inactive lever during the test for reinstatement was very low. A 
repeated measures ANOVA for inactive lever press responses did not reveal significant 
effects. 
. 
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Figure 5: Intra-BNST PACAP38 causes reinstatement to drug-seeking. A,B. PACAP38 
infusion causes significant reinstatement on the active lever (previously associated with 
cocaine delivery) during test for reinstatement compared to the last day of extinction 




 Bilateral intra-BNST infusion of PACAP agonist PACAP38 substantially 
reinstated drug-seeking behavior on the lever previously associated with cocaine 
delivery. This finding suggests a role of BNST PACAP in stress-induced relapse 
A. B. 
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and demonstrates the potential of PACAP infusion to mimic stressor exposure. Hence, 
BNST PACAP is likely critical for behavioral manifestations of stress-induced relapse.  
 These data support findings from prior studies (Erb et al., 2001) implicating an 
important role of extra-hypothalamic CRH in stress-induced, but not drug-prime 
induced, reinstatement to drug seeking. Furthermore, our lab and others (Tsukiyama et 
al., 2011; Hammack & May, 2014; Roman et a., 2014) have argued that PACAP may 
be upstream of BNST CRH and therefore may play a prominent role in modulating an 
extra-hypothalamic CRH system implicated in relapse. Indeed, stressor exposure 
increases PACAP expression in the oval BNST (Roman et al., 2014), a factor that may 
facilitate CRH function in the PVN (associated with stress responses). Researchers 
have also recently shown that PACAP in the lateral parabrachial nucleus (PBn; 
Rouwette et al., 2012; Hammack & May, 2015) projects to the oval BNST, amygdala, 
and other stress-related regions. Hence, we suggest that continued drug-taking and the 
subsequent chronic stress facilitates PACAP expression in the oval BNST which 
activates local CRH function. This reaction then drives CRH activity in the PVN which 
facilitates stress responses. Our proposed model is supported by work conducted by 
Grinevich and colleagues (1997) observing the effects of intracerebroventricular (i.c.v) 
injections of PACAP38 and PACAP6-38 on CRH gene expression in the PVN in rats. 
In situ hybridization analysis showed an increase in the hybridization signal of CRH 
mRNA by PACAP injection that was completely ablated by injection of PACAP6-38. 
Hence, these data suggest PACAP is involved in the regulation of CRH gene 
expression and subsequently might be involved in regulating HPA axis activity 
 26 
(Grinevich et al., 1997). As mentioned previously, we have argued that BNST PACAP 
may be upstream of CRH. Thus, when PACAP6-38 ablates the production of CRH 
mRNA, the role of BNST PACAP in CRH activity becomes clearer: upstream ovBNST 
PACAP may be necessary for the activity of PVN CRH. An alternative hypothesis 
suggests that drug-taking elicits a chronic stress response that activates PACAP in the 
PBn. Indeed, recent work has described the co-localization of PACAP and calcitonin 
gene related peptide (CGRP) in the PBn that extend to the BNST and amygdala 
(Hammack & May, 2015; Missig et al., 2014). 
 Other studies have also observed behavioral responses in PACAP-knockout 
(KO) mice to exogenous substances of abuse such as ethanol (Tanaka et al., 2004) and 
morphine (Abad et al., 2006). Tanaka and colleagues (2004) demonstrated decreased 
responding in PACAP-KO mice to the hypothermic and hypnotic effects of ethanol, 
while morphine withdrawal seemed to be augmented in PAC1 receptor-null mice 
(Abad et al., 2006). These studies further support the role of PACAP as a mediator of 
stressor-like responses elicited by substances of abuse.  
 PACAP plays key roles in the regulation of BNST activity and subsequent stress 
responding. Prior work in our lab has shown that a 1.0 μg PACAP38 infusion into the 
BNST increases corticosterone (CORT; a stress hormone) levels (Lezak et al., 2014). 
Importantly, corticosterone was elevated for about 1hr post-infusion, but not 4 h or 24h 
post-infusion. Increased corticosterone observed in this study after 1μg PACAP38 
infusion suggests that BNST PACAP38 signaling promotes consequences related to 
stressor exposure (Hammack et al., 2010). Indeed, the 1μg PACAP38 dose utilized 
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facilitates behavioral and physiological responses in other stress-related paradigms (i.e. 
anorexic behavior; Lezak et al., 2014; Kocho-Schellenberg et al., 2014; Hammack et 
al., 2010). 
 Several other studies have implicated BNST PACAP38 in corticosterone 
activation that may mimic stressor exposure (Buck et al., 2011). Indeed, after 1μg 
PACAP38 administration, corticosterone levels are similar to those observed after 30 
min of restraint stress (Choi et al., 2007; Radley et al., 2009). Hence, results from our 
research and others suggest that intra-BNST PACAP38 infusion mimics stress effects 
on corticosterone levels, potentially through activation of the HPA axis. 
 Finally, while PACAP can bind to multiple receptor subtypes (PAC1, VPAC1, 
VPAC2), work conducted in our lab has shown that PAC1 receptor activation likely 
mediates BNST PACAP effects. For example, when exposed to a repeated variate 
stress paradigm, anxious rats had an increase in PACAP and PAC1 receptor expression, 
but no elevation in VPAC1 or VPAC2 receptors, or VIP (Hammack, Cheung, et al., 
2009). These results suggest that the anxiety-like behavior observed may be linked to 
an increase specifically in PACAP and PAC1 expression levels. Additionally, as 
mentioned below, infusion of a PAC1 receptor agonist, mazadillan, into the BNST 
blocked effects of stressor exposure while activation of PAC1 receptors caused 
anxiogenic responses (Roman et al., 2014; Missig et al., 2014). These results and others 
implicated an importance of BNST PACAP in the activation of downstream CRH and 
subsequent stress-responses.  
 Combined, these studies suggest an importance of BNST PACAP in stress 
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responding and the activation of the HPA axis. Indeed, in a clinical setting, Ressler and 
colleagues (2011; Andero & Ressler, 2012; Stevens et al., 2014) have shown an 
increase in PACAP expression in patients with post-traumatic stress disorder (PTSD). 
We therefore decided to observe the importance of BNST PACAP signaling in stress-
induced reinstatement to drug seeking, as changes in PACAP signaling have been 
implicated in mental health disorders by HPA axis dysfunction. 
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CHAPTER 3: INTRA-BED NUCLEUS OF THE STRIA TERMINALIS (BNST) 
PITUITARY ADENYLATE CYCLASE-ACTIVATING PEPTIDE 
ANTAGONIST (PACAP6-38) ATTENUATES STRESS-INDUCED 
REINSTATEMENT IN RATS 
 
3.1 Introduction 
 As demonstrated in the previous experiment, BNST PACAP may play an 
important role in stress-induced reinstatement to drug seeking, as a bilateral intra-
BNST infusion of PACAP agonist PACAP38 substantially reinstated drug-seeking on 
the lever previously associated with cocaine delivery. In support of these findings, our 
laboratory has previously shown that the activation of BNST PACAP receptors with 
PACAP38 is sufficient to produce multiple behavioral manifestations of stressor 
exposure, including anorexic-like effects, weight loss, and heightened anxiety-like 
behaviors (Roman et al., 2014). Furthermore, when a PAC1 and VPAC2 receptor 
antagonist (PACAP6-38) was infused into the BNST, these stress-induced 
consequences were blocked, again implicating BNST PACAP in the behavioral 
manifestations of stressor exposure (Roman et al., 2014).  
 In the second study in this set of experiments, we hypothesized that injecting a 
PAC1/VPAC2 receptor antagonist, PACAP6-38, into the BNST directly prior to 
stressor exposure would attenuate drug-seeking behavior after stressor exposure. 
Indeed, Roman et al., 2014 demonstrated that blocking BNST PACAP signaling by 
continuously infusing PACAP6-38 into the BNST during a week of repeated variate 
stress attenuated anxiety-like behavior and accompanying weight alterations typically 
seen after stressor exposure. This chapter describes the effects of PACAP6-38 on 
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stress-induced reinstatement to drug seeking when rats are exposed to an intermittent 
unpredictable footshock (previously shown to cause stress-induced reinstatement; Erb 
et al., 2001). As mentioned in Chapter 1, stressor exposure has been shown to 
significantly increase drug-seeking behavior after a period of extinction; this was 
demonstrated in Experiment 1 (extinction day 13, during the fire drill). Furthermore, 
recent literature (Lezak et al., 2014; Hashimoto et al., 2011; Levran et al., 2015) has 
implicated PACAP as an important polypeptide in the modulation of stress circuitry. 
This set of experiments helps expand the understanding of how BNST PACAP may 
modulate stressor exposure, particularly in a stress-induced reinstatement paradigm. 
These data, and others, will aid in our understanding of how stress systems are 
modulated by BNST PACAP and how stress may contribute to stress-related 
pathologies, such as stress-induced relapse. 
3.2 Methods 
Animals 
 Adult male Sprague-Dawley rats (n=27; 225-250 g upon arrival), obtained from 
Charles River Laboratories (Canada), were individually housed and received water and 
rat chow ad libitum (except when specified). After delivery, rats were allowed to 
habituate to their home cage for one week before undergoing surgeries. Rats were 
maintained on a 12-hr light/dark cycle (lights on at 07:00 hours) and all 
experimentation occurred with lights-on (between 7:30-11:30 am). All procedures were 




 All rats underwent a dual surgery, identical to the one described above (Chapter 
2: Methods, Surgeries), in which they received bilateral intra-BNST cannulation and 
jugular vein catheterization. To maintain patency, catheters were flushed once daily for 
6 days after surgery with 0.2 ml heparinized saline. For the duration of the experiment, 
each animal received 0.1 ml heparinized saline immediately following each self-
administration session to ensure catheter patency. All animals received subcutaneous 
injections of lactated Ringer’s solution and an analgesic (5 mg/kg Metacam, Boehringer 
Ingelheim, Vetmedica, St. Joseph, MO, USA; administered once immediately after the 
dual surgery and once the following day). Once awake, rats were returned to their home 
cages for 7 days post-surgery recovery, during which all rats were observed and 
weighed daily.  
Cocaine Self-Administration/Acquisition 
 Seven days post-surgery, all rats were given the opportunity to self-administer 
cocaine (cocaine hydrochloride 3.0 mg/ml obtained from PENRO Specialty 
Compounding, Colchester, VT, USA) during daily 1-hr sessions for 10 days according 
to a fixed-ratio 1 schedule of reinforcement in manner identical to that described in 
Chapter 2. To review, lever presses on the active lever resulted in a 0.5-s cocaine 
infusion and a 0.5-s flashing presentation of the white stimulus light above the active 
lever. In an effort to help the animals acquire cocaine-seeking behavior, the same 
manipulations made in Experiment 1 were also made in this experiment: all rats 
received mild food restriction (20 g rat chow per day) on days 1-2 of acquisition, 
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and home-cage rat chow was coated lightly on the active lever prior to the rats’ self-
administration session. On days 3-10 of acquisition, all animals received ad libitum 
food and water, and the lever was no longer baited. Additionally, the amount of drug 
delivered per infusion was again decreased over the acquisition period, in order to 
increase cocaine-seeking behaviors, with the following schedule: days 1-3, 1.0 
mg/kg/infusion; days 4-7, 0.75 mg/kg/infusion; days 8-10, 0.50 mg/kg/infusion. 
Extinction 
 Extinction occurred exactly as described in Chapter 2. Rats experienced daily 1-
hr extinction sessions for 20 days during which active lever presses no longer resulted 
in drug delivery reward. At the end of extinction, lever press responses ~0-1 per 
session. 
Reinstatement to cocaine seeking 
 On the day following the last extinction session, rats were split into four groups, 
counterbalanced, that received different treatments. Group Shock-PACAP6-38 received 
a footshock along with a PACAP antagonist infusion; Group Shock-BSA received 
footshock and vehicle infusion; Group NoShock-PACAP6-38 received an infusion of 
PACAP antagonist before being re-exposed to the boxes on test day; and Group 
NoShock-BSA received a vehicle infusion and no stressor exposure. Rats were infused 
with 1.0 μg PACAP6-38 (a PAC1 receptor antagonist; American Peptide Co., 
Sunnyvale, CA; 0.5 μl per side) or equivolume 0.05% BSA vehicle. Infusions were 
carried out according to previously described methods. Immediately following infusion, 
animals were placed back in the operant conditioning chamber and administered 
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five 2.0-mA 5-s footshocks (averaging one shock every 12 min over 1 hr). Active and 
inactive lever presses were recorded during the 1 hr session. 
Histology 
 One day after infusions, rats were anesthetized with Beuthanasia-D (sodium 
pentobarbital; Zoetis Inc., 333 Portage Street, Kalamazoo, MI, USA) solution and 
perfused transcardially as previously described. To summarize, brain tissues were post-
fixed in 10% formalin, cut using a cryostat, dry mounted, stained with cresyl violet and 
visualized under a microscope. Animals with improper cannula placement were 
removed from data analysis. 
Data Analysis 
 Lever press responding during reinstatement was analyzed using repeated 
measure ANOVAs. Pearson’s correlation coefficients were calculated to examine 
relationships between average daily cocaine intake and reinstatement responding. All 
main effects were analyzed with appropriate post-hoc comparisons for significance. 
Effects were noted as significant at p<0.05. Rats that did not complete behavioral 
testing (n=4), or whose cannula were placed beyond the BNST (n=5) were not included 
in data analysis.  
3.3 Results 
 Data from 27 animals were used in the analyses for the tests for reinstatement 
(Group Shock-PACAP6-38, n=9; Group Shock-BSA, n=6; Group NoShock-PACAP6-
38, n=6; Group NoShock-BSA, n=6), as post-test histological examination of injector 
sites for these rats were found to be placed appropriately, and all completed 
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behavioral testing. Four animals did not complete behavioral testing due to gnawed-out 
neck sutures and subsequent jugular catheter exposure; five animals received improper 
cannula placements and were excluded from analysis. Figure 6 portrays the distribution 




Figure 6: BNST Cannula Placements. Cannula placements for Experiment 2 are 
depicted above such that enclosed red circles represent a 1 mm extension beyond the tip 
of the cannula. Rats were included in analysis if their placement resided within a 







 Rats lever pressed, on average, 3.86 (±0.64)  times per hour, 1.0 mg/kg/infusion, 
of cocaine HCl on days 1-3 of acquisition; 3.39 (±0.56) times per hour, 0.75 
mg/kg/infusion on days 4-7 of acquisition; and 7.11 (±0.52) times per hour, 0.5 
mg/kg/infusion on days 8-10 of acquisition (Figure 7). The mean (±SEM) number of 
responses made on the inactive lever on the first day of acquisition was 3.61 (±0.75). 
By the last day of acquisition, responding on the inactive lever was uniformly low (0.76 
(±0.22) lever presses per hour; Figure 7). As in Experiment 1, animals had an affinity 
for active lever presses, as responding solely on the active lever produced cocaine 
delivery; hence, active and inactive lever presses differed by the end of extinction. The 
number of active lever presses was significantly higher (p<0.05) than inactive lever 
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Figure 7: Self-Administration during Experiment 2. 
 
Extinction 
 The mean (±SEM) number of responses made on the active lever on the first two 
days of extinction were 12.38 (±1.34) and 13.93 (±0.72), respectively, in a similar 
manner to the first two days of extinction in Experiment 1. Similarly, by the end of 
extinction, all rats had reached 5 or fewer responses (Figure 8). Inactive lever responses 
remained uniformly low throughout extinction.  
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Figure 8: Extinction Training during Experiment 2. 
 
Test for reinstatement 
 The mean (±SEM) number of lever presses made in the 1 hr session on the last 
day of extinction training was 0.91 (±0.21). The mean (±SEM) number of responses 
made on the active and inactive levers one day after the last day of extinction (during 
the test for reinstatement) is shown in Figure 9. Briefly, animals in the Shock-BSA 
condition lever pressed 9.04 (±0.77) times on the active lever, and 1.33 (±0.44) times 
on the inactive lever. The Shock-BSA group was the only group to demonstrate 
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stress-induced reinstatement behaviors. In contrast, animals in the Shock-PACAP6-38 
group responded on average 1.11 (±0.77) times on the active lever, and 0.44 (±1.15) 
times on the inactive lever; the NoShock-PACAP6-38 group responded, on average, 
1.16 (±1.16) times on the active lever, and 1.16 (±1.08) times on the inactive lever; and 
finally, animals in the NoShock-BSA group lever pressed 0.66 (±1.50) times on the 
active lever and 0.14 (±0.41) times on the inactive lever. Importantly, as will be 
discussed below, the Shock-PACAP6-38 group (Figure 9) demonstrated low levels of 
drug-seeking behavior even after stressor exposure.  
 A repeated measures ANOVA for inactive lever press responses did not reveal 
significant effects. Data from 27 animals were used in the analyses for the tests for 
reinstatement. There was a significant main effect of time on active lever press 
responses between the last day of extinction and test day, F(1, 23)=9.47, p=0.005. 
There was also a significant interaction between both time and shock, F(1,23)=14.031, 
p=0.001, and time and infusion treatment, F(1,23)=7.89, p=0.010, indicating an 
importance of both shock and the administration of the PACAP antagonist on lever 
pressing. Lastly, there was a significant time by shock by infusion treatment 
interaction, F(1,23)=12.10, p=0.002, indicating the necessity of the combined shock 
and treatment variables on lever press activity. As demonstrated in Figure 9, only 
animals who received the footshock paired with a vehicle solution infusion 
demonstrated stress-induced reinstatement; hence, PACAP6-38 blocked stress-induced 
reinstatement to cocaine seeking when the rats were exposed to a stressor. Post hoc 
analyses, comparing antagonist infusion with the vehicle condition, on total 
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responses on the active lever after footshock exposure revealed a significant effect of 
PACAP6-38 (p<0.01). The PAC1 receptor antagonist did not alter responding on the 
inactive lever (F(1,23)=2.3, NS) and responses on the inactive lever remained low (0-3 
lever presses) in the 1 hr test period. Additionally, the number of responses on the 
active lever in the no-footshock condition after injections of PACAP6-38  did not differ 
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Figure 9: Intra-BNST PACAP6-38 attenuates stress-induced reinstatement when paired 
with intermittent, unpredictable footshock. A. Intra-BNST PACAP antagonist 
significantly attenuated stress-induced reinstatement when paired with a footshock 
when compared with the last day of extinction. Only animals who received intra-BNST 
vehicle treatment paired with a footshock demonstrated increased reinstatement to 
drug-seeking behaviors on the lever previously associated with cocaine delivery. B. 









 As mentioned previously, bilateral intra-BNST infusion of PACAP38 is 
sufficient to cause stress-related behaviors, including anorexic-like tendencies, and 
anxiety-like behaviors. Furthermore, bilateral intra-BNST infusion of PAC1/VPAC2 
receptor antagonist PACAP6-38 has been shown to reduce consequences of stressor 
exposure (Roman et al., 2014). Together, these data suggest that BNST PACAP is 
necessary for stress responses, and is an important regulator of stress-related 
pathologies (such as PTSD and anxiety-like disorders; see Hammack et al., 2010; 
Ressler et al., 2011). The present experiment expanded upon this research and supports 
a role of BNST PACAP in stress-induced relapse. Hence, when PAC1/VPAC2 
receptors are blocked, stressor exposure was no longer sufficient to reinstate drug-
seeking behavior. Prior studies have shown that BNST PACAP/PAC1 receptor 
expression is elevated exposure to chronic stress (Hammack & May, 2015). BNST 
PACAP application mimics stressor exposure (see Experiment 1), PAC1/VPAC2 
antagonist blocks consequences of stressor exposure. Combined with prior data, these 
results implicate BNST PACAP and/or PAC1/VPAC2 receptors as important mediators 
of behavioral outputs of stress. 
 As mentioned in Chapter 2, we hypothesize that drug-use activates PACAP 
upstream of CRH in the oval BNST, which then modulates CRH in the PVN to 
stimulate a stress response. Hence, administration of PAC1/VPAC2 antagonist 
PACAP6-38 into the BNST (see Experiment 3: Methods) may block receptors 
responsible for maintaining modulations of downstream PVN CRH (responsible 
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for stress responses). Support for this theory comes from work conducted by Stewart 
and colleagues (2000) describing the role of CRH in stress-induced reinstatement. As 
mentioned previously, CRH receptor antagonist D-Phe CRH was found to block 
footshock-induced reinstatement in animals that had been trained to lever press for 
heroin. Our model suggests that PACAP regulates CRH activity in the PVN and, 
subsequently, stress responses. Hence, blocking upstream PACAP would cause a 
reduction in reinstatement processes similar to those observed after the application of 
D-Phe CRH to the BNST. 
 As mentioned previously, promiscuous PACAP can bind to one of three 
receptors (PAC1, VPAC1, and VPAC2). While current research has not definitively 
stated that one receptor is more likely to mediate stress-induced relapse than another, 
several studies implicate PAC1 receptor activation as a key component of BNST 
PACAP effects. For example, following exposure to a repeated variate stress paradigm, 
rats demonstrated an increase in anxiety-like behavior and an increase in PACAP and 
PAC1 receptor expression, but no change in VPAC1 or VPAC2 receptors, or VIP 
expression (Hammack, Cheung, et al., 2009; Hammack et al., 2010). Furthermore, 
Roman et al., (2014), infused PAC1/VPAC2 receptor antagonist PACAP6-38 into the 
BNST following repeated variate stress exposure which blocked stress-related 
behaviors (i.e., anorexic effects). Combined, these data implicate a role of BNST 
PACAP38 and its PAC1 receptor on stress-related responding.  
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CHAPTER 4: GENERAL DISCUSSION 
 The present experiments were designed to examine the relationship between 
PACAP38, a polypeptide that has been shown to drive BNST CRH, and its receptor 
antagonist, PACAP6-38, in stress-induced reinstatement to drug seeking. We found that 
an infusion of PACAP38 into the BNST was sufficient to reinstate previously-
extinguished cocaine seeking behavior. Furthermore, infusion of PAC1 receptor 
antagonist, PACAP6-38, immediately before stressor exposure, attenuated 
reinstatement to drug seeking when paired with that stressor. 
 Prior data (Hammack, Cheung, et al., 2009) has shown that repeated stressor 
exposure increases both PACAP and PAC1 receptors in the BNST. Additionally, 
preliminary studies in our lab have demonstrated that BNST PACAP expression may 
increase 24 hours after exposure to a single stressor. Hence, one stressor exposure may 
be sufficient to cause neurochemical changes in stress circuitry that manifest 
themselves in behavioral consequences. 
 One theory that may explain the results of this experiment and others (Erb et al., 
2001; Carroll & Comer, 1996; Ettenberg, MacConell, & Geist, 1996; Gerber & Stretch, 
1975; Katner, Magalong & Weiss, 1999; Meil & See, 1996) proposes that the activation 
of stress and anxiety circuits, and the subsequent neurochemical and morphological 
changes in stress circuitry that occurs following drug administration, become part of the 
context of drug taking that then cues drug-seeking (reinstatement) after extinction. 
Homeostatic threats (i.e. stressor exposure) have been shown to activate the HPA axis, 
a system that promotes the neurochemical, morphological, and physiological changes 
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needed to maintain homeostasis. Furthermore, drugs have been shown to activate the 
BNST, and several abusive substances elicit symptoms of anxiety and panic 
(Singewald, Salchner & Sharp, 2003). Acute and chronic drug self-administration has 
also been shown to activate the HPA axis (Garwin & Kleber, 1985; Ramos-Aliaga & 
Werner, 1982), and PACAP and PACAP receptors are highly expressed in brain areas 
that modulate HPA axis activity. Hence, PACAP is important in signaling HPA activity 
(Stroth, Holighaus, et al., 2011), and regulating behavioral responses to stressor 
exposure. Therefore, drugs that activate PACAP signaling, which then activates BNST 
CRH, during periods of self-administration may drive the behavioral and physiological 
stress response that becomes part of the context for drug taking. Our lab proposes that 
after a period of abstinence, or extinction, stressor exposure can then activate re-
activate this circuit, an action that leads to increased BNST PACAP and subsequent 
CRH signaling (previously shown to reinstate drug-seeking behavior).  
 Some drugs (such as cocaine) have been reported to potentiate psychomotor 
stimulant effects, a reaction that may modify the user’s metabolism and the activity of 
neurotransmitters (i.e. increases levels of acetylcholine, Wise & Kiyatkin, 2011) and 
inhibit re-uptake of serotonin, norepinephrine, and dopamine (Little et al., 2014, 
Economidou, Dalley & Everitt, 2011; Navarro et al., 2013). Prior research has 
implicated all these neurotransmitters in the stimulation of hypothalamic CRH 
secretion. Hence, drugs (i.e. cocaine) may activate the HPA axis by releasing 
hypothalamic CRH. Indeed, Calogero et al., (1989) demonstrated that cocaine 
stimulated CRH secretion from hypothalamic regions in vitro. However, 
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work done in our laboratory implicates a role of local BNST PACAP and its projection 
to the PVN in stress-related circuitries. Indeed, activation of the PVN results following 
activation of other extra-hypothalamic regions, such as the amygdala and hippomcapus, 
areas that also mediate emotional behavioral outputs (Herman & Cullinan, 2005).       
 PACAP and PAC1 receptor knock-out mice exhibit decreased anxiety-like 
behavior when compared to control mice (Hashimoto et al., 2001; Girard et al., 2006). 
PAC1 null mice also demonstrate reduced anxiety-like behavior in open field tests 
(used most commonly to determine anxiety-like states; Otto, Martin et al., 2001). In 
relation to the aforementioned proposed theory, PAC1 null mice also demonstrate 
deficits in contextual learning (Otto, Kovalchuk, et al., 2001). Hence, drug use (known 
to activate stress circuits) may activate BNST PACAP, which then cyclically cues for 
drug use after a period of abstinence when stressor exposure again activates the same 
system. Indeed, the activation of BNST PACAP has been shown to increase the 
excitability of CRH neurons in the BNST, which then activates the HPA axis (Choi et 
al., 2007). Moreover, our lab has proposed that PACAPergic fibers may increase CRH 
neuron excitability directly in the BNST oval nucleus (Lezak, et al., 2014), further 
implicating BNST PACAP as an important component of stress-induced reinstatement 
to drug seeking. 
 While our lab hypothesizes that drug administration activates PACAP signaling 
during drug-taking periods, thus driving BNST CRH, and that subsequent stressor 
exposure may re-activate this circuit and potentiate stress-induced reinstatement, stress 
systems may also be activated during withdrawal. In this scenario, stress system 
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activation may provide a contextual cue for withdrawal states. Stressor exposure may 
then provide a context cue that brings the user back to a state of withdrawal, thus 
producing stress-induced relapse. Hence, future experiments may strive to elucidate the 
initiation of PACAP signaling in stress-induced reinstatement. Based on this data and 
others, our lab postulates an increase in PACAP signaling to BNST CRH in response to 
stressor exposure that activates stress systems previously paired with drug use. 
Sources of BNST PACAP 
 As mentioned previously, there are multiple pathways by which stress, drugs, 
and drug-associated stimuli are thought to induce reinstatement to drug-seeking. In 
short, stress and drug-associated stimuli have been shown to activate glutamate 
projections to the ventral tegmental area (VTA) from the prefrontal cortex and 
amygdala; in contrast, drugs of abuse themselves stimulate dopamine release from 
VTA dopamine neurons projecting to the nucleus accumbens. Indeed, relapse induced 
by priming injections of heroin and cocaine appears to activate mesolimbic 
dopaminergic pathways (Stewart, 2000). Stress-induced relapse, as mentioned 
previously, may utilize CRH, HPA axis activation, and subsequent corticosterone 
secretion to activate dopaminergic neurons in the VTA. Hence, CRH has been shown to 
induce relapse by actions in the BNST and blocked by CRH antagonists at this site 
(Stewart, 2000). 
 Several researchers have demonstrated that PACAP activity within the BNST 
originates from the PBn (Missig et al., 2014; Hammack & May, 2015). Conversely, 
PACAP and the mRNA encoding PACAP’s precursor seem most abundant 
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in the hypothalamus (Ghatei et a., 1993). Indeed, PACAP within the BNST binds to 
one of at least two distinct receptors for PACAP, the PAC1 receptor (mentioned in 
Experiment 2), and the VPAC1 receptor (binds PACAP and VIP). However, it is 
important to note that while PACAP6-38 has been used as a PAC1 receptor antagonist, 
it does not discriminate between PAC1 and VPAC2 receptors. Thus, PACAPs role in 
stress-induced reinstatement may be directed toward either of these receptor subtypes.  
 Several studies have reported that during human abstinence from drug use, stress 
exposure often occurs in the presence of contextual cues that had previously been 
associated with drug use (Epstein et al., 2009); these cues may cause an initial lapse in 
abstinence. Additionally, in a similar manner to the drug-cue induced reinstatement 
mentioned above (Chapter 1), human studies have indicated that stressor exposure can 
lead to cue-induced drug craving (Moran-Santa Maria et al., 2015; Fox et al., 2014; 
Mantsch et al., 2015). Furthermore, Sinha and colleagues (1999; 2001) introduced a 
clinical trial based on the rodent stress-induced reinstatement paradigm. In these trials, 
stressor exposure (guided imagery stress and Trier Social Stress Task) caused increased 
drug craving. Additionally, researchers provided a systemic CRH injection to induce 
physiological (i.e. increased corticosl release) and psychological (i.e. increased anxiety) 
stress responses. Since then, many researchers have examined the effects of different 
drugs on stress-induced relapse (Sinha et al., 2007; Fox et al., 2012; McKee et al., 
2014; Moran-Santa Maria et al., 2015), but none have observed the potential effect of 
PACAP on stress-induced relapse. In theory, PACAP treatments may locally target 
BNST PAC1/VPAC2 receptors vis systemic injection in an effort to 
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antagonize receptors and prevent PACAP binding that facilitates stress-responses and, 
subsequently, stress-induced relapse to drug seeking. By blocking BNST PACAP 
activation, PVN CRH activity may be modified, altering responses to stressor exposure. 
Continued research of mechanisms that underlie stress- and drug-cue- induced 
reinstatement after a period of abstinence may lead to the development of viable 
treatments for relapse prevention. 
 Finally, the limited data in human drug abusers indicate that there is a 
reasonable correlation between animal models of reinstatement and drug relapse and 
craving in humans. As research in the field of drug abuse continues, it will remain 
important to develop practical (medication development) and theoretical models to 
combat substance use. Future laboratory-based human models may mimic and 
complement existing laboratory-based rodent models. The potential use of PACAP 
antagonists as a method to prevent stress-induced relapse during times of known 
stressor exposure should be considered. Indeed, it will remain important throughout 
these developmental phases to investigate the concordance between human and animal 
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